Evidence map›Paper›PMID 42507007›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Diagnostic performance of ¹⁸F-FDG PET/CT radiomics-based machine learning models for pancreatic lesion characterisation: Comparison with visual assessment and evaluation of human-radiomics synergy.

Dilsat Firat Arslan, Zeynep Gozde Ozkan, Ali Bayram, Dilara Denizmen Zorba, Emine Goknur Isık, Yasemin Sanli, Duygu Has Simsek, Sukru Mehmet Erturk, Serkan Kuyumcu

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dilsat Firat ArslanDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey. arslandf@istanbul.edu.tr.ORCID http://orcid.org/0000-0003-3133-3134
Zeynep Gozde OzkanDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0360-358X
Ali BayramDepartment of Neuroscience, Biomedical Engineering, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-6588-3479
Dilara Denizmen ZorbaDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-8270-9480
Emine Goknur IsıkDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-3786-8052
Yasemin SanliDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-1267-2379
Duygu Has SimsekDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-6945-2003
Sukru Mehmet ErturkDepartment of Radiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-4086-675X
Serkan KuyumcuDepartment of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-1158-5361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to evaluate the diagnostic performance of ¹⁸F-FDG PET/CT-derived radiomics-based machine learning models for differentiating malignant from benign pancreatic lesions, to compare these models with two sequential stages of visual assessment, and to assess whether incorporation of clinician judgement as a model input provides additional diagnostic gain.

methodsIn this retrospective single-centre study, 853 consecutive patients who underwent ¹⁸F-FDG PET/CT between April 2009 and February 2025 for known or suspected pancreatic lesions were screened, and 466 were included in the final analysis. Final diagnosis was established by histopathology (76.9%) or clinico-radiological follow-up (23.1%). Diagnostic performance was assessed within a five-stage framework consisting of two visual assessment stages and three progressively expanded machine-learning stages. The visual stages comprised first-look assessment based on PET/CT images alone and comprehensive second-look assessment integrating available clinical, laboratory, and multimodal imaging data. The machine-learning stages comprised a hybrid PET + CT radiomics model, an integrated model additionally incorporating clinical, laboratory, semiquantitative PET, and imaging-derived variables, and a human-radiomics synergistic model including the clinician's second-look binary judgement as an input feature. PET-only and CT-only radiomics models were also evaluated as unimodal comparators. Radiomic features were extracted after manual three-dimensional segmentation using 3D Slicer/PyRadiomics, and Random Forest was selected as the final classifier.

resultsOf 466 lesions, 336 (72.1%) were malignant and 130 (27.9%) were benign. First-look visual assessment achieved 93.5% sensitivity, 49.2% specificity, and 81.1% accuracy. Comprehensive second-look assessment improved performance to 97.9% sensitivity, 76.9% specificity, and 92.0% accuracy. Among radiomics-based models, the hybrid PET + CT model outperformed unimodal approaches, achieving 91.1% sensitivity, 66.7% specificity, and 86.8% accuracy. The integrated model did not improve overall accuracy beyond the hybrid model. The human-radiomics synergistic model achieved the highest sensitivity (98.7%) and overall accuracy (93.3%), whereas comprehensive second-look assessment retained slightly higher specificity and NPV.

conclusion¹⁸F-FDG PET/CT radiomics-based machine learning models improved specificity beyond routine first-look visual PET interpretation, approaching the performance of comprehensive second-look visual assessment without requiring additional clinical data. Incorporation of clinician judgement further increased sensitivity, although comprehensive second-look visual assessment by an experienced reader retained the highest specificity and NPV among all approaches. These findings support a complementary, decision-support role for radiomics-based models alongside, rather than in place of, expert visual assessment.

Indexed as

Image Processing, Computer-AssistedMachine LearningPancreatic NeoplasmsPositron Emission Tomography Computed TomographyRadiomicsAdultAgedCohort StudiesFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiopharmaceuticalsReproducibility of ResultsFluorodeoxyglucose F18Radiopharmaceuticals¹⁸F-FDG PET/CTDecision supportMachine learningPancreatic lesionsRadiomicsVisual assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.